0.00Open0.00Pre Close0 Volume0 Open Interest110.00Strike Price0.00Turnover466.97%IV-73.62%PremiumMay 2, 2025Expiry Date46.65Intrinsic Value100Multiplier1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9702Delta0.0040Gamma1.36Leverage Ratio-0.1700Theta-0.0028Rho-1.32Eff Leverage0.0025Vega
Sarepta Therapeutics Stock Discussion
Sarepta Expands Rare Disease Pipeline: FDA Green Light for New LGMD Trial
The Nasdaq gained 316.1 points (1.4%) to 17,750.79, the S&P 500 added 60.63 ticks (1.1%) to 5,675.29 and the DJIA rose 383.32 points (0.9%) to 41,964.63 after the Fed...
The $Nasdaq Composite Index (.IXIC.US)$ shed 304.54 points (1.7%) to a 17,504.12 close, while the $S&P 500 Index (.SPX.US)$ gave up 60.45 ticks (1.1%) to 5,614.66 and the $Dow Jones Industrial Average (.DJI.US)$ lost 260....
No comment yet